Major Histocompatibility Complex Class I (FLA-E*01801) Molecular Structure in Domestic Cats Demonstrates

Ruiying Liang1, Yaping Sun1, Yanjie Liu1,2

  • 1Department of Microbiology and Immunology, College of Veterinary Medicine, China Agricultural University, Beijing, China.

Journal of Virology
|December 22, 2017
PubMed

Insights

Researchers elucidated the structural basis of feline immunodeficiency virus (FIV) peptide presentation by FLA-E*01801, revealing key pocket restrictions for FIV vaccine development. This study identifies potential cytotoxic T lymphocyte (CTL) epitopes for FIV and human immunodeficiency virus (HIV) vaccines.

Area of Science:

  • Immunology
  • Structural Biology
  • Virology

Background:

  • Feline immunodeficiency virus (FIV) serves as a natural model for lentiviral infections.
  • Understanding feline major histocompatibility complex class I (MHC-I) peptide presentation is crucial for vaccine design.
  • FLA-E*01801 is a key molecule in FIV vaccine research.

Purpose of the Study:

  • To determine the crystal structure of FLA-E*01801 complexed with an FIV-derived peptide.
  • To elucidate the structural basis of peptide binding and identify restrictive elements within the FLA-E*01801 molecule.
  • To identify potential cytotoxic T lymphocyte (CTL) epitope peptides from FIV presented by FLA-E*01801.

Main Methods:

  • Crystal structure determination of FLA-E*01801 complexed with an FIV gag peptide (RMA9).
  • Site-directed mutagenesis and circular dichroism (CD) spectroscopy to investigate peptide binding.
  • In vitro refolding experiments to confirm the role of specific amino acid residues.

Main Results:

  • The crystal structure revealed that pocket A of FLA-E*01801 restricts peptide binding, particularly at the first position (P1).
  • Specific residues (Glu63 and Trp167) in pocket A were identified as critical for restricting P1D binding.
  • A binding motif was established: X (except D)-(M/T/A/V/I/L/S)-X-X-X-X-X-X-(R/K), leading to the identification of 125 FIV nonapeptides.
  • The study identified potential FIV CTL epitope peptides presented by FLA-E*01801.

Conclusions:

  • The structural insights into FLA-E*01801 peptide binding provide a foundation for designing FIV and HIV vaccines.
  • Understanding pocket A's restrictive role is vital for selecting appropriate peptide epitopes.
  • The identified FIV nonapeptides and binding motif are valuable for developing peptide-based vaccines and further research into MHC-I-peptide interactions.

Related Concept Videos

Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and...
1.6K
Antigen Processing Pathways01:31

Antigen Processing Pathways

MHC molecules are key players in the immune response, enabling T cells to recognize and respond to specific antigens. They are present on the surface of all nucleated cells in the body and are instrumental in presenting antigens to T cells and activating them. T cells recognize the MHC-antigen complex and initiate an immune response. MHC class I and MHC class II are two main types of MHC molecules, each associated with a distinct antigen processing pathway.
MHC Class I: Presenting Endogenous...
2.4K
Viral Structure00:56

Viral Structure

Viruses are extraordinarily diverse in shape and size, but they all have several structural features in common. All viruses have a core that contains a DNA- or RNA-based genome. The core is surrounded by a protective coat of proteins called the capsid. The capsid is composed of subunits called capsomeres. The capsid and genome-containing core are together known as the nucleocapsid.
74.8K
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.8K